Collectively, these data reveal that artesunate directly interacts with DDX39B to disrupt the DDX39B-TRIM28 binding, which subsequently leads to the degradation of DDX39B protein and inhibition of its pro-metastatic function in NSCLC cells. The gene discussed is DDX39B; the disease is non-small cell lung carcinoma.